SCHEMBL4685073

SCHEMBL4685073

COc1cc(O)cc(/C=C/C(=O)O)c1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.73
KDM4E B2RXH2 6/20 0.62
MAPT P10636 4/20 0.62
PTGS2 P35354 3/20 0.62
ALDH1A1 P00352 3/20 0.62
HPGD P15428 3/20 0.62
HSD17B10 Q99714 3/20 0.62
MEN1 O00255 3/20 0.62
KMT2A Q03164 3/20 0.62
PKM P14618 2/20 0.62
PTGS1 P23219 2/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
USP2 O75604 1/20 0.62
TP53 P04637 1/20 0.62
CYP3A4 P08684 1/20 0.62
TRPV1 Q8NER1 1/20 0.62
THRB P10828 1/20 0.61
ATM Q13315 1/20 0.61
CYP1A1 P04798 3/20 0.59
CYP1B1 Q16678 3/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4685076 1.00 BACE1 (0.73) BACE1KDM4EMAPTPTGS2ALDH1A1
SCHEMBL290941 0.91 THRB (0.67) BACE1KDM4EMAPTPTGS2ALDH1A1
SCHEMBL290940 0.91 THRB (0.67) BACE1KDM4EMAPTPTGS2ALDH1A1
SCHEMBL10900978 0.89 THRB (0.65) BACE1KDM4EMAPTPTGS2ALDH1A1
Hydrochloric Acid SCHEMBL2592367 0.89 THRB (0.65) BACE1KDM4EMAPTPTGS2ALDH1A1
SCHEMBL10900974 0.89 THRB (0.65) BACE1KDM4EMAPTPTGS2ALDH1A1
SCHEMBL3222937 0.84 BACE1 (1.00) BACE1KDM4EMAPTPTGS2ALDH1A1
SCHEMBL3222916 0.84 BACE1 (1.00) BACE1KDM4EMAPTPTGS2ALDH1A1
SCHEMBL19187093 0.84 THRB (0.59) BACE1KDM4EPTGS2ALDH1A1HPGD
SCHEMBL12176946 0.84 THRB (0.59) BACE1KDM4EPTGS2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1386913-B1 PYRROLE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO (JP) 2008-07-16 EP disclosed
US-7220773-B2 Heterocylic amines used as antidiabetic or hyperglycemic agents DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2007-05-22 US disclosed
US-20040162331-A1 Pyrrole derivative DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2004-08-19 US disclosed
EP-1386913-A1 PYRROLE DERIVATIVE SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2004-02-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040162331-A1 Pyrrole derivative SLC5A1, GLP1R, SLC5A2 BACE1 2505/4885KDM4E 847/4885MAPT 3458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.